Live from the NIH registry
Studies recruiting near Thousand Oaks right now
Top 25 of 667 recruiting studies, sorted by proximity — each links to its official registry page
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Kaiser Permanente-Woodland Hills — Woodland Hills, California (15.5 mi)
· Sponsor: SWOG Cancer Research Network
Housing Transitions QUERI
Homelessness
Phase 1
Interventional 153 participants sought
VA Greater Los Angeles Healthcare System, West Los Angeles, CA — West Los Angeles, California (27.4 mi)
· Sponsor: VA Office of Research and Development
Lupus Landmark Study: A Prospective Registry and Biorepository
Systemic Lupus Erythematosus (SLE), Lupus Nephritis
N/A
Observational 3,500 participants sought
Wallace Rheumatic Studies Center — Beverly Hills, California (28.4 mi)
· Sponsor: Lupus Research Alliance
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 600 participants sought
Research Site — Sylmar, California (25.6 mi)
· Sponsor: AstraZeneca
Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa
Hidradenitis Suppurativa
Phase 1
Interventional 24 participants sought
Clinical Trials Research Institute — Thousand Oaks, California (2.6 mi)
· Sponsor: Incyte Corporation
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
Colitis, Ulcerative
Phase 3
Interventional 882 participants sought
Om Research LLC 2 — Oxnard, California (17.2 mi)
· Sponsor: Janssen Research & Development, LLC
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
Non-Small Cell Lung Cancer (NSCLC)
Phase 3
Interventional 750 participants sought
Beverly Hills Cancer Center — Beverly Hills, California (28.4 mi)
· Sponsor: Bristol-Myers Squibb
A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated
Diabetic Macular Edema
Phase 1, Phase 2
Interventional 49 participants sought
California Retina Consultants-Oxnard-70187 — Oxnard, California (17.2 mi)
· Sponsor: Boehringer Ingelheim
Secukinumab Open Label Roll-over Extension Protocol
Autoimmunity, Inflammation
Phase 4
Interventional 1,000 participants sought
Center for Rheumatology Research — Woodland Hills, California (15.5 mi)
· Sponsor: Novartis Pharmaceuticals
RA-PRO PRAGMATIC TRIAL
Rheumatoid Arthritis
Phase 3
Interventional 924 participants sought
Center for Rheumatology Research — Woodland Hills, California (15.5 mi)
· Sponsor: University of Alabama at Birmingham
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
Heart Failure
Phase 3
Interventional 1,500 participants sought
CON-10109, Van Nuys, CA — Van Nuys, California (24.4 mi)
· Sponsor: Colorado Prevention Center
A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
Antineutrophil Cytoplasmic Antibody-associated Vasculitis
Phase 4
Interventional 300 participants sought
Amicis Research Center — Valencia, California (23.1 mi)
· Sponsor: Amgen
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
Oncology, MEK Mutation
Phase 1
Interventional 230 participants sought
UCLA Hematology/Oncology — Westwood, Los Angeles, California (27.1 mi)
· Sponsor: Nested Therapeutics, Inc
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
Non-Small Cell Lung Cancer
Phase 3
Interventional 675 participants sought
Research Site — Beverly Hills, California (28.4 mi)
· Sponsor: AstraZeneca
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
Kaiser Permanente-Woodland Hills — Woodland Hills, California (15.5 mi)
· Sponsor: NRG Oncology
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Percutaneous Coronary Intervention, Peripheral Endovascular Intervention
Phase 4
Interventional 6,000 participants sought
Interventional Cardiology Medical Group — West Hills, California (13.2 mi)
· Sponsor: Duke University
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
Solid Tumor, Non-Small-Cell Lung Cancer
Phase 1
Interventional 364 participants sought
UCLA Santa Monica Hematology Oncology — Santa Monica, California (25.0 mi)
· Sponsor: Astellas Pharma Inc
Comparative Self-collection for Cervical Cancer Screening Pivotal Study
HPV, HPV - Anogenital Human Papilloma Virus Infection
N/A
Interventional 260 participants sought
Integrated Clinical Research — Sherman Oaks, California (24.5 mi)
· Sponsor: Mel Mont Medical
Drug-Induced Sleep Endoscopy for Upper Airway Evaluation in Obstructive Sleep Apnea
Sleep Apnea, Obstructive
Phase 2
Interventional 800 participants sought
UCLA Santa Monica Medical Center — Santa Monica, California (25.0 mi)
· Sponsor: University of California, Los Angeles
A Study of ASP3082 in Adults With Advanced Solid Tumors
Solid Tumor
Phase 1
Interventional 681 participants sought
UCLA Santa Monica Hematology Oncology — Santa Monica, California (25.0 mi)
· Sponsor: Astellas Pharma Inc
A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors
Platinum-resistant Ovarian Cancer, Testicular Cancer
Phase 1
Interventional 156 participants sought
Precision NextGen Oncology & Research Center — Beverly Hills, California (28.4 mi)
· Sponsor: Context Therapeutics Inc.
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Prostate Cancer (Adenocarcinoma)
Phase 3
Interventional 830 participants sought
Kaiser Permanente-Woodland Hills — Woodland Hills, California (15.5 mi)
· Sponsor: Canadian Cancer Trials Group
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
COVID-19 Infection
Phase 3
Interventional 300 participants sought
Hope Clinical Research, Inc. — Canoga Park, California (15.9 mi)
· Sponsor: Pfizer
A Study of VARIPULSE Pulsed Field Ablation (PFA) Catheter and FARAWAVE PFA Catheter in the Treatment of Participants With Persistent Atrial Fibrillation
Atrial Fibrillation
N/A
Interventional 566 participants sought
Community Memorial Hospital — Ventura, California (24.6 mi)
· Sponsor: Biosense Webster, Inc.
A Phase 2, Baseline-Controlled Study Evaluating the Safety and Efficacy of PTX-022 (Sirolimus) Topical Gel 3.9% in the Treatment of Angiokeratomas (LOTU)
Angiokeratomas
Phase 2
Interventional 15 participants sought
Unified Health — Sherman Oaks, California (24.5 mi)
· Sponsor: Palvella Therapeutics, Inc.